Evidence map

ArticlePituitary2025

Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life.

Erlend Gjersdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40830718